Department of Radiology

Publications

2004

Shah K, Tung C-, Yang K, Weissleder R, Breakefield XO. Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. Cancer Res. 2004;64(9):3236-42.

Nehmeh SA, Erdi YE, Pan T, Pevsner A, Rosenzweig KE, Yorke E, et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys. 2004;31(12):3179-86.

Mosconi L, de Santi S, Rusinek H, Convit A, de Leon MJ. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease. Expert Rev Neurother. 2004;4(5):831-49.

Erdi YE, Nehmeh SA, Pan T, Pevsner A, Rosenzweig KE, Mageras G, et al. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med. 2004;45(8):1287-92.

Arias-Mendoza F, Zakian K, Schwartz A, Howe FA, Koutcher JA, Leach MO, et al. Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies. NMR Biomed. 2004;17(6):382-91.

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L-, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240-6.

Spincemaille P, Nguyen TD, Wang Y. View ordering for magnetization prepared steady state free precession acquisition: application in contrast-enhanced MR angiography. Magn Reson Med. 2004;52(3):461-6.

Wunder A, Tung C-, Müller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum. 2004;50(8):2459-65.

Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, et al. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res. 2004;64(12):4069-77.

Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, et al. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. Clin Prostate Cancer. 2004;3(3):174-81.